COMMUNIQUÉS West-GlobeNewswire
-
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in Mesothelioma at ESMO 2024
09/09/2024 - 00:10 -
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
09/09/2024 - 00:05 -
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
09/09/2024 - 00:05 -
SAFE - Nouvel engagement de financement d’un montant minimum net de 3 M€ dans la perspective de la validation du plan de continuation
08/09/2024 - 22:32 -
RYBREVANT®▼ (amivantamab) plus lazertinib show strong favourable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
08/09/2024 - 20:30 -
Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc Analyses, at ERS 2024
08/09/2024 - 15:00 -
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
06/09/2024 - 23:30 -
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/09/2024 - 22:32 -
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06/09/2024 - 22:30 -
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
06/09/2024 - 22:30 -
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
06/09/2024 - 22:30 -
Elutia Celebrates First Year
06/09/2024 - 22:23 -
Pheton Holdings Ltd Announces Closing of Initial Public Offering
06/09/2024 - 22:08 -
Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
06/09/2024 - 22:05 -
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
06/09/2024 - 22:05 -
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/09/2024 - 22:05 -
Codexis Announces New Employment Inducement Grants
06/09/2024 - 22:05 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/09/2024 - 22:05 -
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
06/09/2024 - 22:05
Pages